DOI: 10.1055/s-00000069

Seminars in Liver Disease

Referenz

Lencioni R, Zou JM, Leberre M , et al.
Sorafenib (SOR) or placebo (PL) in combination with transarterial chemoembolization (TACE) with doxorubicin-eluting beads (DEBDOX) for intermediate-stage hepatocellular carcinoma: Phase II, randomized, double-blind SPACE trial.

J Clin Oncol 2012;
30 (Suppl. 04) Abstract LBA154

Bibliographische Angaben herunterladen

Suchen in:
Aufrufen in: